TIGIT and small cell lung carcinoma: To see whether anti-TIGIT antibody could restore effector function of GD2-2840z-CARTs against SCLC, we used RTCA to compare antitumor activity of GD2-2840z-CARTs with or without anti-TIGIT antibody against H446 cells.